Tumour microenvironment on mitochondrial dynamics and chemoresistance in cancer

References

• Zong WX, Rabinowitz JD, White E. Mitochondria and cancer. Mol Cell. 2016;61(5):667–676.
   PubMed Web of Science ®Google Scholar
• Archer SL. Mitochondrial dynamics – mitochondrial fission and fusion in human diseases. N Engl J Med. 2013;369(23):2236–2251.
   PubMed Web of Science ®Google Scholar
• Bahr GF, Zeitler E. Study of mitochondria in rat liver. Quantitative electron microscopy. J Cell Biol. 1962;15:489–501.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.
   PubMed Web of Science ®Google Scholar
• Gururaja Rao S. Mitochondrial changes in cancer. Handb Exp Pharmacol. 2017;240:211–227.
   PubMedGoogle Scholar
• DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism. Sci Adv. 2016;2(5):e1600200.
   PubMed Web of Science ®Google Scholar
• Toyama EQ, Herzig S, Courchet J, et al. Metabolism. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress. Science. 2016;351(6270):275–281.
   PubMed Web of Science ®Google Scholar
• Ko SH, Choi GE, Oh JY, et al. Succinate promotes stem cell migration through the GPR91-dependent regulation of DRP1-mediated mitochondrial fission. Sci Rep. 2017;7(1):12582.
   PubMedGoogle Scholar
• Anastasiou D. Tumour microenvironment factors shaping the cancer metabolism landscape. Br J Cancer. 2017;116(3):277–286.
   PubMed Web of Science ®Google Scholar
• Liesa M, Palacín M, Zorzano A. Mitochondrial dynamics in mammalian health and disease. Physiol Rev. 2009;89(3):799–845.
   PubMed Web of Science ®Google Scholar
• Mannella CA, Lederer WJ, Jafri MS. The connection between inner membrane topology and mitochondrial function. J Mol Cell Cardiol. 2013;62:51–57.
   PubMed Web of Science ®Google Scholar
• Jheng HF, Tsai PJ, Guo SM, et al. Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle. Mol Cell Biol. 2012;32(2):309–319.
   PubMed Web of Science ®Google Scholar
• Cogliati S, Frezza C, Soriano ME, et al. Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency. Cell. 2013;155(1):160–171.
   PubMed Web of Science ®Google Scholar
• Lackner LL. Shaping the dynamic mitochondrial network. BMC Biol. 2014;12(1):35.
   PubMedGoogle Scholar
• Prudent J, McBride HM. Mitochondrial dynamics: ER actin tightens the Drp1 noose. Curr Biol. 2016;26(5):R207–RR209.
   PubMed Web of Science ®Google Scholar
• Korobova F, Ramabhadran V, Higgs HN. An actin-dependent step in mitochondrial fission mediated by the ER-associated formin INF2. Science. 2013;339(6118):464–467.
   PubMed Web of Science ®Google Scholar
• Manor U, Bartholomew S, Golani G, et al. A mitochondria-anchored isoform of the actin-nucleating spire protein regulates mitochondrial division. eLife. 2015;4:e08828.
   Web of Science ®Google Scholar
• Rehklau K, Hoffmann L, Gurniak CB, et al. Cofilin1-dependent actin dynamics control DRP1-mediated mitochondrial fission. Cell Death Dis. 2017;8(10):e3063.
   PubMedGoogle Scholar
• Arasaki K, Shimizu H, Mogari H, et al. A role for the ancient SNARE syntaxin 17 in regulating mitochondrial division. Dev Cell. 2015;32(3):304–317.
   PubMed Web of Science ®Google Scholar
• Onoue K, Jofuku A, Ban-Ishihara R, et al. Fis1 acts as a mitochondrial recruitment factor for TBC1D15 that is involved in regulation of mitochondrial morphology. J Cell Sci. 2013;126(1):176–185.
   PubMed Web of Science ®Google Scholar
• Otera H, Wang C, Cleland MM, et al. Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells. J Cell Biol. 2010;191(6):1141–1158.
   PubMed Web of Science ®Google Scholar
• Otera H, Miyata N, Kuge O, et al. Drp1-dependent mitochondrial fission via MiD49/51 is essential for apoptotic cristae remodeling. J Cell Biol. 2016;212(5):531–544.
   PubMed Web of Science ®Google Scholar
• Yu R, Liu T, Jin SB, et al. MIEF1/2 function as adaptors to recruit Drp1 to mitochondria and regulate the association of Drp1 with Mff. Sci Rep. 2017;7(1):880.
   PubMedGoogle Scholar
• Fan S, Liu B, Sun L, et al. Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p-MFF axis. Oncotarget. 2015;6(17):14885–14904.
   PubMedGoogle Scholar
• Zhao J, Liu T, Jin S, et al. Human MIEF1 recruits Drp1 to mitochondrial outer membranes and promotes mitochondrial fusion rather than fission. EMBO J. 2011;30(14):2762–2778.
   PubMed Web of Science ®Google Scholar
• Liu R, Chan DC. The mitochondrial fission receptor Mff selectively recruits oligomerized Drp1. Mol Biol Cell. 2015;26(24):4466–4477.
   PubMed Web of Science ®Google Scholar
• Ramachandran R. Mitochondrial dynamics: the dynamin superfamily and execution by collusion. Semin Cell Dev Biol. 2018;76:201–212.
   PubMed Web of Science ®Google Scholar
• Francy CA, Clinton RW, Fröhlich C, et al. Cryo-EM studies of Drp1 reveal cardiolipin interactions that activate the helical oligomer. Sci Rep. 2017;7(1):10744.
   PubMedGoogle Scholar
• Macdonald PJ, Stepanyants N, Mehrotra N, et al. A dimeric equilibrium intermediate nucleates Drp1 reassembly on mitochondrial membranes for fission. Mol Biol Cell. 2014;25(12):1905–1915.
   PubMed Web of Science ®Google Scholar
• Pagliuso A, Cossart P, Stavru F. The ever-growing complexity of the mitochondrial fission machinery. Cell Mol Life Sci. 2018;75(3):355–374.
   PubMed Web of Science ®Google Scholar
• Basu K, Lajoie D, Aumentado-Armstrong T, et al. Molecular mechanism of DRP1 assembly studied in vitro by cryo-electron microscopy. PLOS ONE. 2017;12(6):e0179397.
   PubMed Web of Science ®Google Scholar
• Okada R, Yamauchi Y, Hongu T, et al. Activation of the small G protein Arf6 by Dynamin2 through guanine nucleotide exchange factors in endocytosis. Sci Rep. 2015;5:14919.
   PubMed Web of Science ®Google Scholar
• Lee JE, Westrate LM, Wu H, et al. Multiple dynamin family members collaborate to drive mitochondrial division. Nature. 2016;540(7631):139–143.
   PubMed Web of Science ®Google Scholar
• Cho B, Choi SY, Cho HM, et al. Physiological and pathological significance of dynamin-related protein 1 (drp1)-dependent mitochondrial fission in the nervous system. Exp Neurobiol. 2013;22(3):149–157.
   PubMedGoogle Scholar
• Qi X, Disatnik MH, Shen N, et al. Aberrant mitochondrial fission in neurons induced by protein kinase C{delta} under oxidative stress conditions in vivo. Mol Biol Cell. 2011;22(2):256–265.
   PubMed Web of Science ®Google Scholar
• Taguchi N, Ishihara N, Jofuku A, et al. Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J Biol Chem. 2007;282(15):11521–11529.
   PubMed Web of Science ®Google Scholar
• Bae T, Weon KY, Lee JW, et al. Restoration of paclitaxel resistance by CDK1 intervention in drug-resistant ovarian cancer. Carcinogenesis. 2015;36(12):1561–1571.
   PubMed Web of Science ®Google Scholar
• Cai J, Wang J, Huang Y, et al. ERK/Drp1-dependent mitochondrial fission is involved in the MSC-induced drug resistance of T-cell acute lymphoblastic leukemia cells. Cell Death Dis. 2016;7(11):e2459.
   PubMedGoogle Scholar
• Chung LY, Tang SJ, Sun GH, et al. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2. Clin Cancer Res. 2012;18(15):4037–4047.
   PubMed Web of Science ®Google Scholar
• Cho B, Cho HM, Kim HJ, et al. CDK5-dependent inhibitory phosphorylation of Drp1 during neuronal maturation. Exp Mol Med. 2014;46:e105.
   PubMed Web of Science ®Google Scholar
• Mandl MM, Zhang S, Ulrich M, et al. Inhibition of Cdk5 induces cell death of tumor-initiating cells. Br J Cancer. 2017;116(7):912–922.
   PubMed Web of Science ®Google Scholar
• Chou CH, Lin CC, Yang MC, et al. GSK3beta-mediated Drp1 phosphorylation induced elongated mitochondrial morphology against oxidative stress. PLOS ONE. 2012;7(11):e49112.
   PubMed Web of Science ®Google Scholar
• Han XJ, Lu YF, Li SA, et al. CaM kinase I alpha-induced phosphorylation of Drp1 regulates mitochondrial morphology. J Cell Biol. 2008;182(3):573–585.
   PubMed Web of Science ®Google Scholar
• Wang W, Wang Y, Long J, et al. Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells. Cell Metab. 2012;15(2):186–200.
   PubMed Web of Science ®Google Scholar
• Wikstrom JD, Israeli T, Bachar-Wikstrom E, et al. AMPK regulates ER morphology and function in stressed pancreatic beta-cells via phosphorylation of DRP1. Mol Endocrinol. 2013;27(10):1706–1723.
   PubMedGoogle Scholar
• Din S, Mason M, Völkers M, et al. Pim-1 preserves mitochondrial morphology by inhibiting dynamin-related protein 1 translocation. Proc Natl Acad Sci USA. 2013;110(15):5969–5974.
   PubMed Web of Science ®Google Scholar
• Chang CR, Blackstone C. Dynamic regulation of mitochondrial fission through modification of the dynamin-related protein Drp1. Ann N Y Acad Sci. 2010;1201:34–39.
   PubMed Web of Science ®Google Scholar
• Cereghetti GM, Stangherlin A, Martins de Brito O, et al. Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc Natl Acad Sci USA. 2008;105(41):15803–15808.
   PubMed Web of Science ®Google Scholar
• Guo C, Wilkinson KA, Evans AJ, et al. SENP3-mediated desumoylation of Drp1 facilitates interaction with Mff to promote cell death. Sci Rep. 2017;7:43811.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Wang M, Li J, et al. SUMOylation and SENP3 regulate STAT3 activation in head and neck cancer. Oncogene. 2016;35(45):5826–5838.
   PubMed Web of Science ®Google Scholar
• Prudent J, Zunino R, Sugiura A, et al. MAPL SUMOylation of Drp1 stabilizes an ER/mitochondrial platform required for cell death. Mol Cell. 2015;59(6):941–955.
   PubMed Web of Science ®Google Scholar
• Cho DH, Nakamura T, Fang J, et al. S-Nitrosylation of Drp1 mediates β-amyloid-related mitochondrial fission and neuronal injury. Science. 2009;324(5923):102–105.
   PubMed Web of Science ®Google Scholar
• Gawlowski T, Suarez J, Scott B, et al. Modulation of dynamin-related protein 1 (DRP1) function by increased O-linked-beta-N-acetylglucosamine modification (O-GlcNAc) in cardiac myocytes. J Biol Chem. 2012;287(35):30024–30034.
   PubMed Web of Science ®Google Scholar
• Franco A, Kitsis RN, Fleischer JA, et al. Correcting mitochondrial fusion by manipulating mitofusin conformations. Nature. 2016;540(7631):74–79.
   PubMed Web of Science ®Google Scholar
• Cao YL, Meng S, Chen Y, et al. MFN1 structures reveal nucleotide-triggered dimerization critical for mitochondrial fusion. Nature. 2017;542(7641):372–376.
   PubMed Web of Science ®Google Scholar
• Chiche J, Rouleau M, Gounon P, et al. Hypoxic enlarged mitochondria protect cancer cells from apoptotic stimuli. J Cell Physiol. 2010;222(3):648–657.
   PubMed Web of Science ®Google Scholar
• Roy M, Reddy PH, Iijima M, et al. Mitochondrial division and fusion in metabolism. Curr Opin Cell Biol. 2015;33:111–118.
   PubMed Web of Science ®Google Scholar
• van Vliet AR, Verfaillie T, Agostinis P. New functions of mitochondria associated membranes in cellular signaling. Biochim biophys acta. 2014;1843(10):2253–2262.
   PubMed Web of Science ®Google Scholar
• Wang W, Sun Q, Wu Z, et al. Mitochondrial dysfunction-related genes in hepatocellular carcinoma. Front Biosci (Landmark Ed). 2013;18:1141–1149.
   PubMed Web of Science ®Google Scholar
• Sugiura A, Nagashima S, Tokuyama T, et al. MITOL regulates endoplasmic reticulum-mitochondria contacts via Mitofusin2. Mol Cell. 2013;51(1):20–34.
   PubMed Web of Science ®Google Scholar
• Li J, Li Y, Jiao J, et al. Mitofusin 1 is negatively regulated by microRNA 140 in cardiomyocyte apoptosis. Mol Cell Biol. 2014;34(10):1788–1799.
   PubMed Web of Science ®Google Scholar
• Li X, Wang FS, Wu ZY, et al. MicroRNA-19b targets Mfn1 to inhibit Mfn1-induced apoptosis in osteosarcoma cells. Neoplasma. 2014;61(3):265–273.
   PubMed Web of Science ®Google Scholar
• Belenguer P, Pellegrini L. The dynamin GTpase OPA1: more than mitochondria? Biochim biophys acta. 2013;1833(1):176–183.
   PubMed Web of Science ®Google Scholar
• Anand R, Wai T, Baker MJ, et al. The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission. J Cell Biol. 2014;204(6):919–929.
   PubMed Web of Science ®Google Scholar
• Varanita T, Soriano ME, Romanello V, et al. The OPA1-dependent mitochondrial cristae remodeling pathway controls atrophic, apoptotic, and ischemic tissue damage. Cell Metab. 2015;21(6):834–844.
   PubMed Web of Science ®Google Scholar
• Choi SY, Huang P, Jenkins GM, et al. A common lipid links Mfn-mediated mitochondrial fusion and SNARE-regulated exocytosis. Nat Cell Biol. 2006;8(11):1255–1262.
   PubMed Web of Science ®Google Scholar
• Wai T, Langer T. Mitochondrial dynamics and metabolic regulation. Trends Endocrinol Metab. 2016;27(2):105–117.
   PubMed Web of Science ®Google Scholar
• Förtsch J, Hummel E, Krist M, et al. The myosin-related motor protein Myo2 is an essential mediator of bud-directed mitochondrial movement in yeast. J Cell Biol. 2011;194(3):473–488.
   PubMed Web of Science ®Google Scholar
• Caino MC, Ghosh JC, Chae YC, et al. PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasion. Proc Natl Acad Sci USA. 2015;112(28):8638–8643.
   PubMed Web of Science ®Google Scholar
• Caino MC, Seo JH, Wang Y, et al. Syntaphilin controls a mitochondrial rheostat for proliferation-motility decisions in cancer. J Clin Invest. 2017;127(10):3755–3769.
   PubMed Web of Science ®Google Scholar
• Abounit S, Zurzolo C. Wiring through tunneling nanotubes – from electrical signals to organelle transfer. J Cell Sci. 2012;125(5):1089–1098.
   PubMed Web of Science ®Google Scholar
• Vignais ML, Caicedo A, Brondello JM, et al. Cell connections by tunneling nanotubes: effects of mitochondrial trafficking on target cell metabolism, homeostasis, and response to therapy. Stem Cells Int. 2017;2017:6917941.
   PubMed Web of Science ®Google Scholar
• Austefjord MW, Gerdes HH, Wang X. Tunneling nanotubes: diversity in morphology and structure. Communicat Integr Biol. 2014;7(1):e27934.
   PubMedGoogle Scholar
• Plotnikov EY, Babenko VA, Silachev DN, et al. Intercellular transfer of mitochondria. Biochem Mosc. 2015;80(5):542–548.
   PubMed Web of Science ®Google Scholar
• Lu J, Zheng X, Li F, et al. Tunneling nanotubes promote intercellular mitochondria transfer followed by increased invasiveness in bladder cancer cells. Oncotarget. 2017;8(9):15539–15552.
   PubMedGoogle Scholar
• Pasquier J, Guerrouahen BS, Al Thawadi H, et al. Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance. J Transl Med. 2013;11:94.
   PubMed Web of Science ®Google Scholar
• Jang M, Kim SS, Lee J. Cancer cell metabolism: implications for therapeutic targets. Mol Med 2013;45(10):e45.
   Google Scholar
• Dupuy F, Tabariès S, Andrzejewski S, et al. PDK1-dependent metabolic reprogramming dictates metastatic potential in breast cancer. Cell Metab. 2015;22(4):577–589.
   PubMed Web of Science ®Google Scholar
• Holmström KM, Finkel T. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat Rev Mol Cell Biol. 2014;15(6):411–421.
   PubMed Web of Science ®Google Scholar
• Liou G-Y, Storz P. Reactive oxygen species in cancer. Free Radic Res. 2010;44(5):479–496.
   PubMed Web of Science ®Google Scholar
• Li X, Fang P, Mai J, et al. Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers. J Hematol Oncol. 2013;6(1):19.
   PubMedGoogle Scholar
• Mei H, Sun S, Bai Y, et al. Reduced mtDNA copy number increases the sensitivity of tumor cells to chemotherapeutic drugs. Cell Death Dis. 2015;6:e1710.
   PubMed Web of Science ®Google Scholar
• Chen N, Wen S, Sun X, et al. Elevated mitochondrial DNA copy number in peripheral blood and tissue predict the opposite outcome of cancer: a meta-analysis. Sci Rep. 2016;6:37404.
   PubMed Web of Science ®Google Scholar
• Guaragnella N, Giannattasio S, Moro L. Mitochondrial dysfunction in cancer chemoresistance. Biochem Pharmacol. 2014;92(1):62–72.
   PubMed Web of Science ®Google Scholar
• Hori A, Yoshida M, Shibata T, et al. Reactive oxygen species regulate DNA copy number in isolated yeast mitochondria by triggering recombination-mediated replication. Nucleic Acids Res. 2009;37(3):749–761.
   PubMed Web of Science ®Google Scholar
• Prakash A, Doublié S. Base excision repair in the mitochondria. J Cell Biochem. 2015;116(8):1490–1499.
   PubMed Web of Science ®Google Scholar
• Ballista-Hernández J, Martínez-Ferrer M, Vélez R, et al. Mitochondrial DNA integrity is maintained by APE1 in carcinogen-induced colorectal cancer. Mol Cancer Res. 2017;15(7):831–841.
   PubMed Web of Science ®Google Scholar
• Gao Y, Katyal S, Lee Y, et al. DNA ligase III is critical for mtDNA integrity but not Xrcc1-mediated nuclear DNA repair. Nature. 2011;471(7337):240–244.
   PubMed Web of Science ®Google Scholar
• Douarre C, Sourbier C, Dalla Rosa I, et al. Mitochondrial topoisomerase I is critical for mitochondrial integrity and cellular energy metabolism. PLOS ONE. 2012;7(7):e41094.
   PubMed Web of Science ®Google Scholar
• Panieri E, Santoro MM. ROS homeostasis and metabolism: a dangerous liason in cancer cells. Cell Death Disease. 2016;7(6):e2253.
   PubMedGoogle Scholar
• Idelchik MDPS, Begley U, Begley TJ, et al. Mitochondrial ROS control of cancer. Semin Cancer Biol. 2017;47:57–66.
   PubMed Web of Science ®Google Scholar
• Weinberg F, Hamanaka R, Wheaton WW, et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci USA. 2010;107(19):8788–8793.
   PubMed Web of Science ®Google Scholar
• Kim B, Jung JW, Jung J, et al. PGC1alpha induced by reactive oxygen species contributes to chemoresistance of ovarian cancer cells. Oncotarget. 2017;8(36):60299–60311.
   PubMedGoogle Scholar
• Zhao G, Cao K, Xu C, et al. Crosstalk between mitochondrial fission and oxidative stress in paraquat-induced apoptosis in mouse alveolar type II cells. Int J Biol Sci. 2017;13(7):888–900.
   PubMed Web of Science ®Google Scholar
• Wu S, Zhou F, Zhang Z, et al. Mitochondrial oxidative stress causes mitochondrial fragmentation via differential modulation of mitochondrial fission-fusion proteins. FEBS J. 2011;278(6):941–954.
   PubMed Web of Science ®Google Scholar
• Cho U, Kim B, Kim S, et al. Pro-inflammatory M1 macrophage enhances metastatic potential of ovarian cancer cells through NF-κB activation. Mol Carcinog. 2018;57(2):235–242.
   PubMed Web of Science ®Google Scholar
• Alshaker HA, Matalka KZ. IFN-γ, IL-17 and TGF-β involvement in shaping the tumor microenvironment: the significance of modulating such cytokines in treating malignant solid tumors. Cancer Cell Int. 2011;11(1):33.
   PubMedGoogle Scholar
• Zhang J, Zhang Y, Wu W, et al. Guanylate-binding protein 2 regulates Drp1-mediated mitochondrial fission to suppress breast cancer cell invasion. Cell Death Dis. 2017;8(10):e3151.
   PubMedGoogle Scholar
• White JP, Puppa MJ, Sato S, et al. IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse. Skelet Muscle. 2012;2:14.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang L, Gao YF, et al. MicroRNA-106b induces mitochondrial dysfunction and insulin resistance in C2C12 myotubes by targeting mitofusin-2. Mol Cell Endocrinol. 2013;381(1–2):230–240.
   PubMed Web of Science ®Google Scholar
• Romanello V, Guadagnin E, Gomes L, et al. Mitochondrial fission and remodelling contributes to muscle atrophy. EMBO J. 2010;29(10):1774–1785.
   PubMed Web of Science ®Google Scholar
• Ayantunde AA, Parsons SL. Pattern and prognostic factors in patients with malignant ascites: a retrospective study. Ann Oncol. 2007;18(5):945–949.
   PubMed Web of Science ®Google Scholar
• Kim S, Kim B, Song YS. Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer. Cancer Sci. 2016;107(9):1173–1178.
   PubMed Web of Science ®Google Scholar
• Kim S, Gwak H, Kim HS, et al. Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro. Oncotarget. 2016;7(50):83148–83159.
   PubMedGoogle Scholar
• Izuishi K, Kato K, Ogura T, et al. Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy. Cancer Res. 2000;60(21):6201–6207.
   PubMed Web of Science ®Google Scholar
• Li P, Zhang D, Shen L, et al. Redox homeostasis protects mitochondria through accelerating ROS conversion to enhance hypoxia resistance in cancer cells. Sci Rep. 2016;6:22831.
   PubMed Web of Science ®Google Scholar
• Eales KL, Hollinshead KE, Tennant DA. Hypoxia and metabolic adaptation of cancer cells. Oncogenesis. 2016;5:e190.
   PubMed Web of Science ®Google Scholar
• Wang H, Zheng S, Liu M, et al. The effect of propofol on mitochondrial fission during oxygen-glucose deprivation and reperfusion injury in rat hippocampal neurons. PLOS ONE. 2016;11(10):e0165052.
   PubMed Web of Science ®Google Scholar
• Casazza A, Di Conza G, Wenes M, et al. Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment. Oncogene. 2014;33(14):1743–1754.
   PubMed Web of Science ®Google Scholar
• Bos R, van Diest PJ, de Jong JS, et al. Hypoxia-inducible factor-1 alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology. 2005;46(1):31–36.
   PubMed Web of Science ®Google Scholar
• Salabei JK, Hill BG. Mitochondrial fission induced by platelet-derived growth factor regulates vascular smooth muscle cell bioenergetics and cell proliferation. Redox Biol. 2013;1:542–551.
   PubMed Web of Science ®Google Scholar
• Wu W, Lin C, Wu K, et al. FUNDC1 regulates mitochondrial dynamics at the ER–mitochondrial contact site under hypoxic conditions. EMBO J. 2016;35(13):1368–1384.
   PubMed Web of Science ®Google Scholar
• Han XJ, Yang ZJ, Jiang LP, et al. Mitochondrial dynamics regulates hypoxia-induced migration and antineoplastic activity of cisplatin in breast cancer cells. Int J Oncol. 2015;46(2):691–700.
   PubMed Web of Science ®Google Scholar
• Diebold I, Hennigs JK, Miyagawa K, et al. BMPR2 preserves mitochondrial function and DNA during reoxygenation to promote endothelial cell survival and reverse pulmonary hypertension. Cell Metab. 2015;21(4):596–608.
   PubMed Web of Science ®Google Scholar
• Rossignol R, Gilkerson R, Aggeler R, et al. Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res. 2004;64(3):985–993.
   PubMed Web of Science ®Google Scholar
• Rambold AS, Kostelecky B, Elia N, et al. Tubular network formation protects mitochondria from autophagosomal degradation during nutrient starvation. Proc Natl Acad Sci USA. 2011;108(25):10190–10195.
   PubMed Web of Science ®Google Scholar
• Kitaoka Y, Nakazato K, Ogasawara R. Combined effects of resistance training and calorie restriction on mitochondrial fusion and fission proteins in rat skeletal muscle. J Appl Physiol (1985). 2016;121(3):806–810.
   PubMed Web of Science ®Google Scholar
• Lee JY, Kapur M, Li M, et al. MFN1 deacetylation activates adaptive mitochondrial fusion and protects metabolically challenged mitochondria. J Cell Sci. 2014;127(Pt 22):4954–4963.
   PubMed Web of Science ®Google Scholar
• Li J, Huang Q, Long X, et al. Mitochondrial elongation-mediated glucose metabolism reprogramming is essential for tumour cell survival during energy stress. Oncogene. 2017;36(34):4901–4912.
   PubMed Web of Science ®Google Scholar
• Cheng CT, Kuo CY, Ouyang C, et al. Metabolic stress-induced phosphorylation of KAP1 Ser473 blocks mitochondrial fusion in breast cancer cells. Cancer Res. 2016;76(17):5006–5018.
   PubMed Web of Science ®Google Scholar
• Bonuccelli G, Tsirigos A, Whitaker-Menezes D, et al. Ketones and lactate “fuel” tumor growth and metastasis: evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle. 2010;9(17):3506–3514.
   PubMed Web of Science ®Google Scholar
• Guido C, Whitaker-Menezes D, Lin Z, et al. Mitochondrial fission induces glycolytic reprogramming in cancer-associated myofibroblasts, driving stromal lactate production, and early tumor growth. Oncotarget. 2012;3(8):798–810.
   PubMedGoogle Scholar
• Cui J, Li Z, Zhuang S, et al. Melatonin alleviates inflammation-induced apoptosis in human umbilical vein endothelial cells via suppression of Ca2+-XO-ROS-Drp1-mitochondrial fission axis by activation of AMPK/SERCA2a pathway. Cell Stress Chaperones. 2018;23(2):281–293.
   PubMed Web of Science ®Google Scholar
• Rojas A, González I, Morales E, et al. Diabetes and cancer: looking at the multiligand/RAGE axis. World J Diabetes. 2011;2(7):108–113.
   PubMedGoogle Scholar
• Kang R, Tang D, Schapiro NE, et al. The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics. Oncogene. 2014;33(5):567–577.
   PubMed Web of Science ®Google Scholar
• Cui Y, Guo G. Immunomodulatory function of the tumor suppressor p53 in host immune response and the tumor microenvironment. Int J Mol Sci. 2016;17(11).
   Web of Science ®Google Scholar
• Scharping NE, Menk AV, Moreci RS, et al. The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction. Immunity. 2016;45(2):374–388.
   PubMed Web of Science ®Google Scholar
• Buck MD, O’Sullivan D, Klein Geltink RI, et al. Mitochondrial dynamics controls T cell fate through metabolic programming. Cell. 2016;166(1):63–76.
   PubMed Web of Science ®Google Scholar
• Suen DF, Norris KL, Youle RJ. Mitochondrial dynamics and apoptosis. Genes Dev. 2008;22(12):1577–1590.
   PubMed Web of Science ®Google Scholar
• Horbay R, Bilyy R. Mitochondrial dynamics during cell cycling. Apoptosis. 2016;21(12):1327–1335.
   PubMed Web of Science ®Google Scholar
• Altieri DC. Mitochondria on the move: emerging paradigms of organelle trafficking in tumour plasticity and metastasis. Br J Cancer. 2017;117(3):301–305.
   PubMed Web of Science ®Google Scholar
• Rehman J, Zhang HJ, Toth PT, et al. Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer. FASEB J. 2012;26(5):2175–2186.
   PubMed Web of Science ®Google Scholar
• Pal HC, Prasad R, Katiyar SK. Cryptolepine inhibits melanoma cell growth through coordinated changes in mitochondrial biogenesis, dynamics and metabolic tumor suppressor AMPKalpha1/2-LKB1. Sci Rep. 2017;7(1):1498.
   PubMedGoogle Scholar
• Farrand L, Byun S, Kim JY, et al. Piceatannol enhances cisplatin sensitivity in ovarian cancer via modulation of p53, X-linked inhibitor of apoptosis protein (XIAP), and mitochondrial fission. J Biol Chem. 2013;288(33):23740–23750.
   PubMed Web of Science ®Google Scholar
• Farrand L, Kim JY, Im-Aram A, et al. An improved quantitative approach for the assessment of mitochondrial fragmentation in chemoresistant ovarian cancer cells. PLOS ONE. 2013;8(9):e74008.
   PubMed Web of Science ®Google Scholar
• Chowdhury SR, Ray U, Chatterjee BP, et al. Targeted apoptosis in ovarian cancer cells through mitochondrial dysfunction in response to Sambucus nigra agglutinin. Cell Death Dis. 2017;8(5):e2762.
   PubMedGoogle Scholar
• Zhou X, Wang HY, Wu B, et al. Ginkgolide K attenuates neuronal injury after ischemic stroke by inhibiting mitochondrial fission and GSK-3beta-dependent increases in mitochondrial membrane permeability. Oncotarget. 2017;8(27):44682–44693.
   PubMedGoogle Scholar
• Fan Z, Yu H, Cui N, et al. ABT737 enhances cholangiocarcinoma sensitivity to cisplatin through regulation of mitochondrial dynamics. Exp Cell Res. 2015;335(1):68–81.
   PubMed Web of Science ®Google Scholar
• Anvekar RA, Asciolla JJ, Lopez-Rivera E, et al. Sensitization to the mitochondrial pathway of apoptosis augments melanoma tumor cell responses to conventional chemotherapeutic regimens. Cell Death Dis. 2012;3(11):e420.
   PubMedGoogle Scholar
• Gregory-Bass RC, Olatinwo M, Xu W, et al. Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to apoptosis. Int J Cancer. 2008;122(9):1923–1930.
   PubMed Web of Science ®Google Scholar
• Zhang L, Fang B. Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Ther. 2005;12(3):228–237.
   PubMed Web of Science ®Google Scholar
• Ke S, Zhou T, Yang P, et al. Gold nanoparticles enhance TRAIL sensitivity through Drp1-mediated apoptotic and autophagic mitochondrial fission in NSCLC cells. Int J Nanomater. 2017;12:2531–2551.
   Google Scholar
• Zhang G, Frederick DT, Wu L, et al. Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors. J Clin Invest. 2016;126(5):1834–1856.
   PubMed Web of Science ®Google Scholar
• Kong B, Tsuyoshi H, Orisaka M, et al. Mitochondrial dynamics regulating chemoresistance in gynecological cancers. Ann N Y Acad Sci. 2015;1350:1–16.
   PubMed Web of Science ®Google Scholar
• Huang Q, Zhan L, Cao H, et al. Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFkB and TP53 pathways. Autophagy. 2016;12(6):999–1014.
   PubMed Web of Science ®Google Scholar
• Yang Z, Feng Z, Gu J, et al. microRNA-488 inhibits chemoresistance of ovarian cancer cells by targeting Six1 and mitochondrial function. Oncotarget. 2017;8(46):80981–80993.
   PubMedGoogle Scholar
• Wang X, Gerdes HH. Transfer of mitochondria via tunneling nanotubes rescues apoptotic PC12 cells. Cell Death Differ. 2015;22(7):1181–1191.
   PubMed Web of Science ®Google Scholar
• Han H, Hu J, Yan Q, et al. Bone marrow-derived mesenchymal stem cells rescue injured H9c2 cells via transferring intact mitochondria through tunneling nanotubes in an in vitro simulated ischemia/reperfusion model. Mol Med Rep. 2016;13(2):1517–1524.
   PubMed Web of Science ®Google Scholar
• Desir S, Dickson EL, Vogel RI, et al. Tunneling nanotube formation is stimulated by hypoxia in ovarian cancer cells. Oncotarget. 2016;7(28):43150–43161.
   PubMedGoogle Scholar
• Belin BJ, Lee T, Mullins RD. DNA damage induces nuclear actin filament assembly by Formin -2 and Spire-½ that promotes efficient DNA repair. [corrected]. eLife. 2015;4:e07735.
   PubMed Web of Science ®Google Scholar
• Huo Y, Zheng Z, Chen Y, et al. Downregulation of vimentin expression increased drug resistance in ovarian cancer cells. Oncotarget. 2016;7(29):45876–45888.
   PubMedGoogle Scholar
• Wei L, Surma M, Shi S, et al. Novel insights into the roles of Rho kinase in cancer. Arch immunol ther exp (Warsz). 2016;64(4):259–278.
   PubMed Web of Science ®Google Scholar
• Joshi HP, Subramanian IV, Schnettler EK, et al. Dynamin 2 along with microRNA-199a reciprocally regulate hypoxia-inducible factors and ovarian cancer metastasis. Proc Natl Acad Sci USA. 2014;111(14):5331–5336.
   PubMed Web of Science ®Google Scholar
• Kong B, Wang Q, Fung E, et al. p53 is required for cisplatin-induced processing of the mitochondrial fusion protein L-Opa1 that is mediated by the mitochondrial metallopeptidase Oma1 in gynecologic cancers. J Biol Chem. 2014;289(39):27134–27145.
   PubMed Web of Science ®Google Scholar
• Fiorini C, Cordani M, Padroni C, et al. Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine. Biochim biophys acta. 2015;1853(1):89–100.
   PubMed Web of Science ®Google Scholar
• Prieto J, León M, Ponsoda X, et al. Early ERK1/2 activation promotes DRP1-dependent mitochondrial fission necessary for cell reprogramming. Nat Commun. 2016;7:11124.
   PubMed Web of Science ®Google Scholar
• Tsuyoshi H, Wong VKW, Han Y, et al. Saikosaponin-d, a calcium mobilizing agent, sensitizes chemoresistant ovarian cancer cells to cisplatin-induced apoptosis by facilitating mitochondrial fission and G2/M arrest. Oncotarget. 2017;8(59):99825–99840.
   PubMedGoogle Scholar
• Shirane M, Nakayama KI. Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis. Nat Cell Biol. 2003;5(1):28–37.
   PubMed Web of Science ®Google Scholar
• Zaja I, Bai X, Liu Y, et al. Cdk1, PKCdelta and calcineurin-mediated Drp1 pathway contributes to mitochondrial fission-induced cardiomyocyte death. Biochem Biophys Res Commun. 2014;453(4):710–721.
   PubMed Web of Science ®Google Scholar
• Hung TH, Chen CM, Tseng CP, et al. FZD1 activates protein kinase C delta-mediated drug-resistance in multidrug-resistant MES-SA/Dx5 cancer cells. Int J Biochem Cell Biol. 2014;53:55–65.
   PubMed Web of Science ®Google Scholar
• Ferrer CM, Lynch TP, Sodi VL, et al. O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway. Mol Cell. 2014;54(5):820–831.
   PubMed Web of Science ®Google Scholar
• Satoh M, Hamamoto T, Seo N, et al. Differential sublocalization of the dynamin-related protein OPA1 isoforms in mitochondria. Biochem Biophys Res Commun. 2003;300(2):482–493.
   PubMed Web of Science ®Google Scholar
• Stiburek L, Cesnekova J, Kostkova O, et al. YME1L controls the accumulation of respiratory chain subunits and is required for apoptotic resistance, cristae morphogenesis, and cell proliferation. Mol Biol Cell. 2012;23(6):1010–1023.
   PubMed Web of Science ®Google Scholar
• Li M, Yin J, Mao N, et al. Upregulation of phosphorylated cofilin 1 correlates with Taxol resistance in human ovarian cancer in vitro and in vivo. Oncol Rep. 2013;29(1):58–66.
   PubMed Web of Science ®Google Scholar
• Chen J, Kobayashi M, Darmanin S, et al. Pim-1 plays a pivotal role in hypoxia-induced chemoresistance. Oncogene. 2009;28(28):2581–2592.
   PubMed Web of Science ®Google Scholar
• Hung TH, Hsu SC, Cheng CY, et al. Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/beta-catenin pathway. Oncotarget. 2014;5(23):12273–12290.
   PubMedGoogle Scholar